Diabetes and stroke prevention: a review.

Area of Science:

• Cardiovascular Medicine
• Endocrinology
• Neurology

Background:

• Stroke and diabetes mellitus are prevalent, vascular diseases sharing risk factors like hypertension and dyslipidemia.
• Abnormal glucose regulation, including diabetes, affects up to two-thirds of acute stroke patients.
• While aggressive glucose management post-stroke shows no outcome benefit, managing other vascular risks is promising.

Purpose of the Study:

• To review the relationship between stroke and diabetes mellitus.
• To emphasize the importance of managing cardiovascular risk factors in diabetic individuals for stroke prevention and post-stroke outcomes.
• To provide recommendations for managing hypertension, lipids, and antiplatelet therapy in this population.

Main Methods:

• Review of existing literature on stroke, diabetes, and cardiovascular risk factors.
• Analysis of treatment guidelines for hypertension and dyslipidemia in diabetic patients.
• Discussion of the role of antiplatelet therapy in stroke prevention for diabetics.

Main Results:

• Aggressive post-stroke glucose management does not improve outcomes or reduce recurrent stroke incidence.
• Active management of hypertension (target 140/80 mmHg, ACE inhibitors preferred) and dyslipidemia (statins) can prevent stroke and improve outcomes in diabetics.
• Antiplatelet treatment is essential, though specific recommendations for diabetics are not detailed.

Conclusions:

• Effective management of hypertension and dyslipidemia is vital for primary and secondary stroke prevention in diabetic patients.
• Focusing on blood pressure and lipid control, alongside antiplatelet therapy, is key to minimizing disability.
• Integrated care addressing vascular risk factors is imperative for the growing population of individuals with both diabetes and stroke.